Medical Research
Sanders Tri-Institutional Therapeut Discovery Institute Inc Co Weill C
NEW YORK, NY
Total revenue
$16.6M
Total expenses
$16.6M
Net assets
—
Grants received
—
EIN
463673346
Tax year
2024
Mission
To further and improve health and the diagnosis, prevention and treatment of disease.
Programs
1 program
The institute facilitates more efficient sharing of core facilities between the three partner institutions and forms industry partnerships with pharmaceutical and biotech companies to further advance drug research. It seeks to create intellectual property that can be further developed by an open field of industry collaborators. The majority of such services relate to medicinal chemistry support.
Financials
FY 2024
Revenue
Expenses
People
16 listed
PETER T MEINKE PHD
SANDERS DIRECTOR
$628K
40 hrs/wk
CARL NATHAN MD
BOARD MEMBER
—
0.5 hrs/wk
NATHANIEL HEINTZ PHD
BOARD MEMBER
—
0.5 hrs/wk
SELWYN VICKERS MD
BOARD MEMBER
—
0.5 hrs/wk
MICHAEL P VITALE
TREASURER
—
0.5 hrs/wk
DEREK TAN PHD
BOARD MEMBER
—
0.5 hrs/wk
RICHARD P LIFTON MD PHD
BOARD MEMBER
—
0.5 hrs/wk
ROBERT HARRINGTON MD
BOARD MEMBER
—
0.5 hrs/wk
BARRY COLLER MD
BOARD MEMBER
—
0.5 hrs/wk
BARBARA HEMPSTEAD MD
BOARD MEMBER
—
0.5 hrs/wk
DAVID SCHEINBERG MD PHD
BOARD MEMBER
—
0.5 hrs/wk
MANUEL BACA
VICE PRESIDENT, BIOLOGICS
$403K
40 hrs/wk
PATRICIA AHA
VICE PRESIDENT, OPRATIONS
$301K
40 hrs/wk
NIGEL LIVERTON PHD
VICE PRESIDENT, CHEMISTRY
$290K
40 hrs/wk
PAUL BALDERES
SR. DIRECTOR
$281K
40 hrs/wk
SANDRA LORBER
VICE PRESIDENT, FINANCE
$255K
40 hrs/wk
Independent contractors
WUXI
PROF SVCS-RESEARCH
ABLEXIS LLC
PROF SVCS-RESEARCH
SINGLE CELL TECHNOLOGY
PROF SVCS-RESEARCH
WUXI BIOLOGICS
PROF SVCS-RESEARCH
VIVA BIOTECH (SHANGHAI) LTD
PROF SVCS-RESEARCH